share_log

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

Needham Reiterates Buy on Avidity Biosciences, Maintains $35 Price Target

Needham重申买入Avidity Biosciences,维持35美元的目标股价
Moomoo 24/7 ·  04/11 07:23

Needham analyst Joseph Stringer reiterates Avidity Biosciences (NASDAQ:RNA) with a Buy and maintains $35 price target.

Needham分析师约瑟夫·斯金格重申Avidity Biosciences(纳斯达克股票代码:RNA)的买入,并维持35美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发